BR0202674A - Compostos de benzenossulfonamida, processo para a sua preparação e composições farmacêuticas contendo os mesmos - Google Patents
Compostos de benzenossulfonamida, processo para a sua preparação e composições farmacêuticas contendo os mesmosInfo
- Publication number
- BR0202674A BR0202674A BR0202674-0A BR0202674A BR0202674A BR 0202674 A BR0202674 A BR 0202674A BR 0202674 A BR0202674 A BR 0202674A BR 0202674 A BR0202674 A BR 0202674A
- Authority
- BR
- Brazil
- Prior art keywords
- group
- preparation
- pharmaceutical compositions
- compositions containing
- processes
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000008331 benzenesulfonamides Chemical class 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002102 aryl alkyloxo group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0109338A FR2827287B1 (fr) | 2001-07-13 | 2001-07-13 | Nouveaux derives de benzene sulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0202674A true BR0202674A (pt) | 2003-05-06 |
Family
ID=8865461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0202674-0A BR0202674A (pt) | 2001-07-13 | 2002-07-10 | Compostos de benzenossulfonamida, processo para a sua preparação e composições farmacêuticas contendo os mesmos |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6589956B2 (enExample) |
| EP (1) | EP1275644A1 (enExample) |
| JP (1) | JP4138382B2 (enExample) |
| KR (1) | KR100498864B1 (enExample) |
| CN (1) | CN1168715C (enExample) |
| AR (1) | AR036340A1 (enExample) |
| AU (1) | AU2002300093B2 (enExample) |
| BR (1) | BR0202674A (enExample) |
| CA (1) | CA2394037C (enExample) |
| EA (1) | EA005403B1 (enExample) |
| FR (1) | FR2827287B1 (enExample) |
| HU (1) | HUP0202286A2 (enExample) |
| MX (1) | MXPA02006852A (enExample) |
| NO (1) | NO323868B1 (enExample) |
| NZ (1) | NZ520140A (enExample) |
| PL (1) | PL354948A1 (enExample) |
| ZA (1) | ZA200205598B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2621164A1 (en) * | 2005-08-26 | 2007-03-01 | Shionogi & Co., Ltd. | Derivative having ppar agonistic activity |
| WO2014047427A2 (en) | 2012-09-21 | 2014-03-27 | Vanderbilt University | Substituted benzofuran, benzothiophene and indole mcl-1 inhibitors |
| EP3038618B1 (en) | 2013-08-28 | 2020-10-14 | Vanderbilt University | Substituted indole mcl-1 inhibitors |
| US10533010B2 (en) | 2014-03-27 | 2020-01-14 | Vanderbilt University | Substituted indole Mcl-1 inhibitors |
| US9949965B2 (en) | 2014-10-17 | 2018-04-24 | Vanderbilt University | Tricyclic indole Mcl-1 inhibitors and uses thereof |
| CN109153643B (zh) | 2016-03-04 | 2022-06-21 | 范德比尔特大学 | 取代的吲哚mcl-1抑制剂 |
| MX2022007947A (es) * | 2019-12-24 | 2022-07-27 | Sumitomo Pharma Co Ltd | Derivado de amida de acido alifatico. |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3468882A (en) * | 1966-10-07 | 1969-09-23 | Sterling Drug Inc | Phenylhydrazone derivatives as intermediates for preparing indoles |
| GB8419575D0 (en) * | 1984-08-01 | 1984-09-05 | Glaxo Group Ltd | Chemical compounds |
| KR940007458B1 (ko) * | 1991-11-21 | 1994-08-18 | 주식회사 금성사 | 박막 트랜지스터 제조 방법 |
| TW219358B (enExample) * | 1991-12-20 | 1994-01-21 | Hokuriku Pharmaceutical | |
| CA2152160A1 (en) * | 1992-12-21 | 1994-07-07 | Tomoyuki Ikemoto | N-substituted indole derivative |
| GB9317764D0 (en) * | 1993-08-26 | 1993-10-13 | Pfizer Ltd | Therapeutic compound |
| FR2712591B1 (fr) * | 1993-11-19 | 1996-02-09 | Pf Medicament | Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique. |
| CN1092639C (zh) * | 1995-01-06 | 2002-10-16 | 东丽株式会社 | 苯稠合杂环衍生物及其用途 |
| WO1997016446A1 (en) * | 1995-11-02 | 1997-05-09 | Merck Sharp & Dohme Limited | Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues thereof, their preparation and their use as selective agonists of 5-ht1-like receptors |
| GB9523250D0 (en) * | 1995-11-14 | 1996-01-17 | Merck Sharp & Dohme | Therapeutic agents |
| GB9523243D0 (en) * | 1995-11-14 | 1996-01-17 | Merck Sharp & Dohme | Therapeutic agents |
-
2001
- 2001-07-13 FR FR0109338A patent/FR2827287B1/fr not_active Expired - Fee Related
-
2002
- 2002-07-08 PL PL02354948A patent/PL354948A1/xx not_active Application Discontinuation
- 2002-07-10 BR BR0202674-0A patent/BR0202674A/pt not_active IP Right Cessation
- 2002-07-10 JP JP2002200910A patent/JP4138382B2/ja not_active Expired - Fee Related
- 2002-07-11 MX MXPA02006852A patent/MXPA02006852A/es active IP Right Grant
- 2002-07-11 EP EP02291746A patent/EP1275644A1/fr not_active Withdrawn
- 2002-07-12 HU HU0202286A patent/HUP0202286A2/hu unknown
- 2002-07-12 AR ARP020102608A patent/AR036340A1/es not_active Application Discontinuation
- 2002-07-12 ZA ZA200205598A patent/ZA200205598B/xx unknown
- 2002-07-12 US US10/195,031 patent/US6589956B2/en not_active Expired - Fee Related
- 2002-07-12 EA EA200200665A patent/EA005403B1/ru not_active IP Right Cessation
- 2002-07-12 NO NO20023389A patent/NO323868B1/no not_active IP Right Cessation
- 2002-07-12 NZ NZ520140A patent/NZ520140A/en unknown
- 2002-07-12 AU AU2002300093A patent/AU2002300093B2/en not_active Ceased
- 2002-07-13 KR KR10-2002-0040945A patent/KR100498864B1/ko not_active Expired - Fee Related
- 2002-07-15 CA CA002394037A patent/CA2394037C/fr not_active Expired - Fee Related
- 2002-07-15 CN CNB021241619A patent/CN1168715C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030007173A (ko) | 2003-01-23 |
| NZ520140A (en) | 2003-09-26 |
| EA005403B1 (ru) | 2005-02-24 |
| AR036340A1 (es) | 2004-09-01 |
| US6589956B2 (en) | 2003-07-08 |
| CN1397550A (zh) | 2003-02-19 |
| CA2394037C (fr) | 2008-04-29 |
| HU0202286D0 (enExample) | 2002-09-28 |
| FR2827287B1 (fr) | 2003-10-31 |
| CN1168715C (zh) | 2004-09-29 |
| NO323868B1 (no) | 2007-07-16 |
| NO20023389D0 (no) | 2002-07-12 |
| NO20023389L (no) | 2003-01-14 |
| AU2002300093B2 (en) | 2007-07-12 |
| JP4138382B2 (ja) | 2008-08-27 |
| HK1050681A1 (en) | 2003-07-04 |
| MXPA02006852A (es) | 2005-07-25 |
| HUP0202286A2 (hu) | 2003-08-28 |
| PL354948A1 (en) | 2003-01-27 |
| ZA200205598B (en) | 2003-03-27 |
| CA2394037A1 (fr) | 2003-01-13 |
| KR100498864B1 (ko) | 2005-07-04 |
| EA200200665A1 (ru) | 2003-02-27 |
| EP1275644A1 (fr) | 2003-01-15 |
| US20030109533A1 (en) | 2003-06-12 |
| FR2827287A1 (fr) | 2003-01-17 |
| JP2003064055A (ja) | 2003-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9911783A (pt) | Compostos cìclicos substituìdos, processo para sua preparação e composições farmacêuticas que os contêm | |
| BR0314379A (pt) | Quinazolinonas espirocondensadas e a sua utilização como inibidores de fosfodiesterase | |
| EA200701176A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
| AR034268A1 (es) | Compuestos derivados de piperidina, su uso en preparacion de medicamentos, composicion farmaceutica, metodo de tratamiento y proceso para su preparacion | |
| BR0212185A (pt) | Compostos e métodos para a preparação de compostos | |
| BR0111667A (pt) | Novos compostos | |
| BR0016395A (pt) | Derivados de adamantano | |
| BR0206433A (pt) | Composto, composição farmacêutica, processo para a prepapação de um composto, e, uso de um composto | |
| BR0210464A (pt) | Composto, composição farmacêutica, processo para preparar um composto, e, uso de um composto | |
| HUP0301391A2 (hu) | Piperazin- és piperidinszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| BR9912138A (pt) | Compostos cìclicos úteis no tratamento de dislipidemia, aterosclerose e diabetes, composções farmacêuticas e processo para preparação | |
| BR0304203A (pt) | Processo para a sìntese industrial de tetraésteres de ácido 5-[bis (carboximetil)amino]-3-carboximetil-4-ciano-2-tiofen ocarboxìlico e aplicação à sintese de sais bivalentes de ácido ranélico e seus hidratos | |
| BR9805031A (pt) | Compostos de naftaleno, processo para sua preparação e composições farmacêuticas contendo os mesmos. | |
| BR0202674A (pt) | Compostos de benzenossulfonamida, processo para a sua preparação e composições farmacêuticas contendo os mesmos | |
| BRPI0406500A (pt) | processo farmacêutico e compostos preparados pelo mesmo | |
| DE602004029355D1 (de) | Sulfopyrrolderivate | |
| BR9813217A (pt) | Tetraciclos, processo para a produção dos mesmos e preparações farmacêuticas contendo estes compostos | |
| BR0100107A (pt) | Compostos de benzenossulfonamida, um processo para sua preparação e composições farmacêuticas que contêm os mesmos | |
| BR0016921A (pt) | Tetrahidropiridinas, processo para sua preparação e composições farmacêuticas que as contêm | |
| BR0104471A (pt) | Compostos de ciclobutenodiona, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos | |
| BR0106248A (pt) | Inibidores de metaloprotease, processo para a sua preparação e composições farmacêuticas contendo os mesmos | |
| BR0213359A (pt) | Aralquiltetrahidropiridinas, sua preparação e composições farmacêuticas contendo as mesmas | |
| BR0309130A (pt) | Derivados de acil-3-carboxifenil-uréia, processo para a sua preparação e sua aplicação | |
| BR0002287A (pt) | Compostos de piridina ou piperidina substituìdas, processo para preparação deles e composições farmacêuticas contendo-os | |
| BRPI0504780A (pt) | compostos de benzotiadiazina, processo para sua preparação e composições farmacêuticas contendo os mesmos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE 8A. ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011. |